tiprankstipranks
Nurix Therapeutics Faces Financial Risks Amid Supreme Court Regulatory Shift
PremiumCompany AnnouncementsNurix Therapeutics Faces Financial Risks Amid Supreme Court Regulatory Shift
2M ago
Nurix Therapeutics Reports Solid Progress and Strong Pipeline
Premium
Company Announcements
Nurix Therapeutics Reports Solid Progress and Strong Pipeline
2M ago
Nurix Therapeutics price target raised to $27 from $26 at RBC Capital
Premium
The Fly
Nurix Therapeutics price target raised to $27 from $26 at RBC Capital
2M ago
Nurix Therapeutics Unveils 2025 Objectives and Achievements
PremiumCompany AnnouncementsNurix Therapeutics Unveils 2025 Objectives and Achievements
3M ago
Nurix Therapeutics outlines 2025 goals, objective
Premium
The Fly
Nurix Therapeutics outlines 2025 goals, objective
3M ago
Nurix Therapeutics sees cash runway into 1H27
Premium
The Fly
Nurix Therapeutics sees cash runway into 1H27
3M ago
Nurix Therapeutics holds a pharmaceutical update conference call
PremiumThe FlyNurix Therapeutics holds a pharmaceutical update conference call
4M ago
Nurix Therapeutics initiated with an Outperform at BMO Capital
Premium
The Fly
Nurix Therapeutics initiated with an Outperform at BMO Capital
4M ago
Nurix Therapeutics announces PRIME designation for NX-5948 from EMA
Premium
The Fly
Nurix Therapeutics announces PRIME designation for NX-5948 from EMA
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100